Concord Medical Services Holdings Ltd
NYSE:CCM
Intrinsic Value
Concord Medical Services Holding Ltd. engages in the operation of radiotherapy and diagnostic imaging centers. [ Read More ]
The intrinsic value of one CCM stock under the Base Case scenario is 6.0445 USD. Compared to the current market price of 0.5039 USD, Concord Medical Services Holdings Ltd is Undervalued by 92%.
Fundamental Analysis
Balance Sheet Decomposition
Concord Medical Services Holdings Ltd
Current Assets | 850.8m |
Cash & Short-Term Investments | 243.4m |
Receivables | 98.1m |
Other Current Assets | 509.3m |
Non-Current Assets | 5.2B |
Long-Term Investments | 423.1m |
PP&E | 3.9B |
Intangibles | 915.5m |
Other Non-Current Assets | 25.5m |
Current Liabilities | 1.3B |
Accounts Payable | 131.6m |
Accrued Liabilities | 457.4m |
Short-Term Debt | 213.2m |
Other Current Liabilities | 533.8m |
Non-Current Liabilities | 6.6B |
Long-Term Debt | 2.3B |
Other Non-Current Liabilities | 4.3B |
Earnings Waterfall
Concord Medical Services Holdings Ltd
Revenue
|
612.3m
CNY
|
Cost of Revenue
|
-713.4m
CNY
|
Gross Profit
|
-101.1m
CNY
|
Operating Expenses
|
-453.9m
CNY
|
Operating Income
|
-555m
CNY
|
Other Expenses
|
89m
CNY
|
Net Income
|
-466m
CNY
|
Free Cash Flow Analysis
Concord Medical Services Holdings Ltd
CCM Profitability Score
Profitability Due Diligence
Concord Medical Services Holdings Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
Score
Concord Medical Services Holdings Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
CCM Solvency Score
Solvency Due Diligence
Concord Medical Services Holdings Ltd's solvency score is 25/100. The higher the solvency score, the more solvent the company is.
Score
Concord Medical Services Holdings Ltd's solvency score is 25/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CCM Price Targets Summary
Concord Medical Services Holdings Ltd
According to Wall Street analysts, the average 1-year price target for CCM is 1.2 USD .
Shareholder Return
CCM Price
Concord Medical Services Holdings Ltd
Average Annual Return | -3.86% |
Standard Deviation of Annual Returns | 25.83% |
Max Drawdown | -92% |
Market Capitalization | 21.9m USD |
Shares Outstanding | 43 417 200 |
Percentage of Shares Shorted | 0.06% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Concord Medical Services Holding Ltd. engages in the operation of radiotherapy and diagnostic imaging centers. The company is headquartered in Beijing, Beijing and currently employs 851 full-time employees. The company went IPO on 2009-12-11. The firm is also engaged in hospital operations. The firm's segments are network and premium cancer hospital. The firm operates a network of radiotherapy and diagnostic imaging centers in China. Its network consists of approximately 130 cooperative centers based in over 70 hospitals, spanning approximately 60 cities across 25 provinces and administrative regions in China. Its network includes approximately 60 radiotherapy centers and over 60 diagnostic imaging centers and approximately seven centers. The firm's cooperative centers are equipped with a primary unit of medical equipment, such as a linear accelerator, head gamma knife system, body gamma knife system, positron emission tomography-computed tomography (PET-CT) scanner or magnetic resonance imaging (MRI) scanner.